Translational Considerations to Improve Response and Overcome Therapy Resistance in Immunotherapy for Hepatocellular Carcinoma

SIMPLE SUMMARY: Immunotherapeutic approaches became a promising treatment option and an intensive field of research in liver cancer. Despite promising results in preclinical studies, only moderate response rates have been reported in phase III clinical trials and predictive biomarkers are still miss...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinrich, Sophia, Castven, Darko, Galle, Peter R., Marquardt, Jens U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563159/
https://www.ncbi.nlm.nih.gov/pubmed/32899197
http://dx.doi.org/10.3390/cancers12092495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563159/
https://www.ncbi.nlm.nih.gov/pubmed/32899197
http://dx.doi.org/10.3390/cancers12092495

Ejemplares similares